Suchergebnisse - "Strub-Wourgaft, Nathalie"

PubPharm (63)

41

Inclusion of women susceptible to and becoming pregnant in preregistration clinical trials in low- and middle-income countries : A proposal for neglected tropical diseases

enthalten in: PLoS neglected tropical diseases | 2020

von Couderc-Pétry, M. | Eléfant, E. | Wasunna, M. | +3

42

Innovative Partnerships for the Elimination of Human African Trypanosomiasis and the Development of Fexinidazole

enthalten in: Tropical medicine and infectious disease | 2020

von Neau, P. | Hänel, H. | Lameyre, V. | +2

43

The consequence of COVID-19 on the global supply of medical products : Why Indian generics matter for the world?

enthalten in: F1000Research | 2020

von Guerin, P. | Singh-Phulgenda, S. | Strub-Wourgaft, N.

44

Field effectiveness of new visceral leishmaniasis regimens after 1 year following treatment within public health facilities in Bihar, India

enthalten in: PLoS neglected tropical diseases | 2019

von Goyal, V. | Burza, S. | Pandey, K. | +12

45

A randomized trial of AmBisome monotherapy and AmBisome and miltefosine combination to treat visceral leishmaniasis in HIV co-infected patients in Ethiopia

enthalten in: PLoS neglected tropical diseases | 2019

von Diro, E. | Blesson, S. | Edwards, T. | +19

46

Recent Development of Visceral Leishmaniasis Treatments : Successes, Pitfalls, and Perspectives

enthalten in: Clinical microbiology reviews | 2018

von Alves, F. | Bilbe, G. | Blesson, S. | +14

47

Field safety and effectiveness of new visceral leishmaniasis treatment regimens within public health facilities in Bihar, India

enthalten in: PLoS neglected tropical diseases | 2018

von Goyal, V. | Mahajan, R. | Pandey, K. | +17

48

Treatment of adult chronic indeterminate Chagas disease with benznidazole and three E1224 dosing regimens : a proof-of-concept, randomised, placebo-controlled trial

enthalten in: The Lancet. Infectious diseases | 2018

von Torrico, F. | Gascon, J. | Ortiz, L. | +52

CommentIn: Lancet Infect Dis. 2018 Apr;18(4):363-365. - PMID 29352705

49

Oral fexinidazole for late-stage African Trypanosoma brucei gambiense trypanosomiasis : a pivotal multicentre, randomised, non-inferiority trial

enthalten in: Lancet (London, England) | 2018

von Mesu, V. | Kalonji, W. | Bardonneau, C. | +23

ErratumIn: Lancet. 2018 Jan 13;391(10116):124. - PMID 29129438

50

Systematic review of clinical trials assessing the therapeutic efficacy of visceral leishmaniasis treatments : A first step to assess the feasibility of establishing an individual patient data sharing platform

enthalten in: PLoS neglected tropical diseases | 2017

von Bush, J. | Wasunna, M. | Alves, F. | +6